Hypotonic stimulation of the Na+ active transport in frog skeletal muscle: role of the cytoskeleton.
Hypotonicity produces a marked activation of the Na+ pump in frog sartorius muscle. The increase in net Na+ efflux under hypotonic conditions occurs despite the reductions in [Na+]i that are due to fibre swelling and Na+ loss. The pump density (ouabain binding) increases not only upon reduction of the medium osmotic pressure (pi) from its normal value (pi = 1) to one-half (pi = 0.5), but also in muscles that are returned to pi = 1 after equilibration in pi = 2 medium. The equilibration in pi = 2 medium does not affect pump density. Ouabain-binding increments cannot be ascribed to a rise in the Na+-K+ exchange rate of a fixed number of pumps: they also occurred in the continued presence of a saturating concentration of ouabain (50 microM). Under those conditions, the pi = 1 pi = 0.5 transfer produced a 43 % increase in pump sites, while the pi = 2 pi = 1 transfer induced a rise of 46 %. Actinomycin D did not alter the stimulation of Na+ extrusion elicited by hypotonicity, suggesting that de novo synthesis of pumps was not involved in the increase of the apparent number of pump sites. Disruption of microtubules by colchicine (100 microM) and intermediate filaments by acrylamide (4 mM) did not alter the hypotonic effect. Likewise, genistein (100 microM), a specific inhibitor of tyrosine kinase, did not affect significantly the hypotonic response. Microfilament-disrupting agents like cytochalasin B (5 microM) and latrunculin B (10 microM) reduced the increase in Na+ efflux induced by pi = 1 pi = 0.5 transfer by about 35 % and 72 %, respectively. Latrunculin B reduced the increases in pump density generated by pi = 1 pi = 0.5 and pi = 2 pi = 1 transfers by about 79 % and 91 %, respectively. The results suggest that the membrane stretch due to hypotonic fibre volume increase would promote a microfilament-mediated insertion of submembranous spare Na+ pumps in the sarcolemma and, consequently, the rise in active Na+ transport.
Venosa
R A
RA
Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120, Argentina. rvenosa@atlas.med.unlp.edu.ar
D000199:Actins / Q000378:metabolism; D000818:Animals; D001001:Anura / Q000378:metabolism; D001693:Biological Transport, Active / Q000187:drug effects / Q000502:physiology*; D002316:Cardiotonic Agents / Q000378:metabolism / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism*; D007038:Hypotonic Solutions / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D008840:Microfilament Proteins / Q000378:metabolism; D008870:Microtubules / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D010042:Ouabain / Q000378:metabolism / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects / Q000378:metabolism; D013054:Spectrophotometry, Atomic
D000199:Actins; D002316:Cardiotonic Agents; D007038:Hypotonic Solutions; D008840:Microfilament Proteins; D010042:Ouabain; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium